Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Ehrmann

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|February 1, 1989
Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid statusD A Ehrmann, M Weinberg, D H Sarne
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenismR L Rosenfield, R B Barnes, D A Ehrmann
Endocrine Reviews|June 1, 1995
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretionD A Ehrmann, R B Barnes, R L Rosenfield
The Journal of Clinical Investigation|August 10, 2000
Interactions between insulin resistance and insulin secretion in the development of glucose intoleranceM K Cavaghan, D A Ehrmann, K S Polonsky
The New England Journal of Medicine|March 2, 1989
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndromeR B Barnes, R L Rosenfield, S Burstein, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 16, 2000
Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenismR L Rosenfield, K Ghai, D A Ehrmann, et al.
Annals of the New York Academy of Sciences|May 28, 1993
Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenismR L Rosenfield, D A Ehrmann, R B Barnes, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center studyR L Rosenfield, N Perovic, D A Ehrmann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiencyR B Barnes, D A Ehrmann, D F Brigell, et al.
The Journal of Clinical Investigation|August 1, 1997
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose toleranceM K Cavaghan, D A Ehrmann, M M Byrne, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|February 1, 1989
Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid statusD A Ehrmann, M Weinberg, D H Sarne
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenismR L Rosenfield, R B Barnes, D A Ehrmann
Endocrine Reviews|June 1, 1995
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretionD A Ehrmann, R B Barnes, R L Rosenfield
The Journal of Clinical Investigation|August 10, 2000
Interactions between insulin resistance and insulin secretion in the development of glucose intoleranceM K Cavaghan, D A Ehrmann, K S Polonsky
The New England Journal of Medicine|March 2, 1989
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndromeR B Barnes, R L Rosenfield, S Burstein, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 16, 2000
Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenismR L Rosenfield, K Ghai, D A Ehrmann, et al.
Annals of the New York Academy of Sciences|May 28, 1993
Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenismR L Rosenfield, D A Ehrmann, R B Barnes, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center studyR L Rosenfield, N Perovic, D A Ehrmann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiencyR B Barnes, D A Ehrmann, D F Brigell, et al.
The Journal of Clinical Investigation|August 1, 1997
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose toleranceM K Cavaghan, D A Ehrmann, M M Byrne, et al.
Pageof 4